siRNA, Anti-TAF1A, LNA-modified(CAT#: SIRGT29716WQ-LNA)

The product SIRGT29716WQ-LNA is a type of small interfering RNA (siRNA) that targets TAF1A gene and regulates the expression of gene. The siRNA interferes with the expression of TAF1A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001201536.1; NM_005681.3; NM_139352.2
Alternative Names MGC:17061; RAFI48; SL1; TAFI48
Related Diseases Familial Isolated Dilated Cardiomyopathy
Purification HPLC
Target Gene
Gene ID 9015
Uniprot ID Q15573

Related Products